NIDA CENTER FOR GENETIC STUDIES

RELEASE DATE:  December 18, 2003

NOTICE:  NOT-DA-04-021

RFP AVAILABLE:  N01DA-4-7745

National Institute on Drug Abuse (NIDA)
 (http://www.nida.nih.gov/)

The National Institute on Drug Abuse plans to procure services from a 
qualified organization having the capability to maintain and expand for 
the Division of Treatment Research and Development the NIDA Center for 
Genetic Studies.  Offerors must have the capacity to accomplish in an 
efficient, rapid, and cost-effective manner the tasks outlined in the 
Statement of Work.  The main functions include the receipt of 13,000-
17,000 new clinical, diagnostic, pedigree structure, and other data and 
blood samples from approximately 18-25 grant projects.  The contractor 
shall process data and biomaterials to create databases, cell lines, 
serum, DNA, and possibly RNA.  The contractor shall provide storage and 
wide distribution of all data and materials in the NIDA Human Genetics 
Initiative (approximately 25,000) to qualified investigators in the 
scientific community (including scientists in industry, the NIH 
intramural program, and public and private universities) granted access 
by NIDA.   This is a follow-on procurement to contract number N01DA-9-
7079 with Rutgers, The State University of New Jersey.  NIDA expects to 
award a 3-year contract with 2 option years. Options for additional 
quantities also are included.  RFP No. N01DA-4-7745 is available and 
may be accessed through the Internet at: 
http://www.eps.gov/spg/HHS/NIH/NIDA/N01DA%2D4%2D7745/listing.html 
or through the NIDA website address: http://www.nida.nih.gov/RFP/RFPList.html.  
The streamlined RFP for this acquisition includes only the Work 
Statement, Deliverables and Reporting Requirements, Special 
Requirements and Mandatory Qualifications, Technical Evaluation 
Criteria, and other necessary Proposal Preparation Instructions.  The 
electronic RFP contains all information needed to submit an offer.  No 
printed version of the solicitation document or source list is 
available.  All responsible offerors may submit a proposal for the 
government’s consideration.  Proposals will be due on January 6, 2004.

Point of Contact:
         Diane M. Loeb, Contract Specialist
         National Institute on Drug Abuse, NIH
         Contracts Management Branch, OPRM
         6101 Executive Boulevard
         Room 260, MSC 8402
         Bethesda, Maryland  20892-8402
         Electronic Mail Address: dl294p@nih.gov
         Telephone:  (301) 443-6677
         Fax:  (301) 443-7595

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.